Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$4.22 - $8.89 $49,618 - $104,528
-11,758 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$8.36 - $21.08 $98,296 - $247,858
11,758 New
11,758 $101,000
Q3 2021

Nov 12, 2021

SELL
$17.57 - $28.95 $121,250 - $199,783
-6,901 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$24.14 - $37.68 $166,590 - $260,029
6,901 New
6,901 $200,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $50.4M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.